Login / Signup

Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of COVID-19 with mild-to-moderate severity: A retrospective observational study.

Jeong Eun LeeSoon Ok LeeJeonghun HeoDong Wan KimMi Ran ParkHyunjin SonDongkeun KimKye-Hyung KimShinwon LeeSun Hee Lee
Published in: Antiviral therapy (2021)
Based on our study results, HCQ shows no apparent advantage compared to LPV/r for preventing progression to severe disease in patients with COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • combination therapy
  • adipose tissue
  • diffusion weighted imaging
  • skeletal muscle
  • magnetic resonance
  • insulin resistance